Fioretos T - Search Results

1

Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy.

Thielen N, Richter J, Baldauf M, Barbany G, Fioretos T, Giles F, Gjertsen BT, Hochhaus A, Schuurhuis GJ, Sopper S, Stenke L, Thunberg S, Wolf D, Ossenkoppele G, Porkka K, Janssen J, Mustjoki S. Thielen N, et al. Among authors: fioretos t. Clin Cancer Res. 2016 Aug 15;22(16):4030-8. doi: 10.1158/1078-0432.CCR-15-2791. Epub 2016 Mar 22. Clin Cancer Res. 2016. PMID: 27006491

2

Molecular analysis of Philadelphia-positive childhood chronic myeloid leukemia.

Fioretos T, Heim S, Garwicz S, Ludvigsson J, Mitelman F. Fioretos T, et al. Leukemia. 1992 Jul;6(7):723-5. Leukemia. 1992. PMID: 1625493

3

Remarkably long survival of a patient with Ph1-positive chronic myeloid leukemia and 5' bcr rearrangement.

Johansson B, Mertens F, Fioretos T, Heim S, Kristoffersson U, Mandahl N, Bartram CR, Mitelman F. Johansson B, et al. Among authors: fioretos t. Leukemia. 1990 Jun;4(6):448-9. Leukemia. 1990. PMID: 2359344

4

Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia.

Fioretos T, Nilsson PG, Aman P, Heim S, Kristoffersson U, Malm C, Simonsson B, Turesson I, Mitelman F. Fioretos T, et al. Leukemia. 1993 Aug;7(8):1225-31. Leukemia. 1993. PMID: 8350622

5

Abberant cytogenetic evolution pattern of Philadelphia-positive chronic myeloid leukemia treated with interferon-alpha.

Johansson B, Fioretos T, Billström R, Mitelman F. Johansson B, et al. Among authors: fioretos t. Leukemia. 1996 Jul;10(7):1134-8. Leukemia. 1996. PMID: 8683992

6

BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion.

Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F, Höglund M. Andreasson P, et al. Among authors: fioretos t. Genes Chromosomes Cancer. 1997 Nov;20(3):299-304. Genes Chromosomes Cancer. 1997. PMID: 9365838

7

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

Johansson B, Fioretos T, Mitelman F. Johansson B, et al. Among authors: fioretos t. Acta Haematol. 2002;107(2):76-94. doi: 10.1159/000046636. Acta Haematol. 2002. PMID: 11919388 Review.

8

A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23).

Barbouti A, Höglund M, Johansson B, Lassen C, Nilsson PG, Hagemeijer A, Mitelman F, Fioretos T. Barbouti A, et al. Among authors: fioretos t. Cancer Res. 2003 Mar 15;63(6):1202-6. Cancer Res. 2003. PMID: 12649177

9

Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.

Svensson E, Vidovic K, Lassen C, Richter J, Olofsson T, Fioretos T, Gullberg U. Svensson E, et al. Among authors: fioretos t. Leukemia. 2007 Dec;21(12):2485-94. doi: 10.1038/sj.leu.2404924. Epub 2007 Aug 30. Leukemia. 2007. PMID: 17728783

10

Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation.

Håkansson P, Nilsson B, Andersson A, Lassen C, Gullberg U, Fioretos T. Håkansson P, et al. Among authors: fioretos t. Genes Chromosomes Cancer. 2008 Apr;47(4):267-75. doi: 10.1002/gcc.20528. Genes Chromosomes Cancer. 2008. PMID: 18181176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page